Antibody-drug conjugate (Bighat Biosciences/Eli Lilly and company)

N/A

Report date: 2025/05/20 16:56:16

Base Information

Drug NameAntibody-drug conjugate (Bighat Biosciences/Eli Lilly and company)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBighat Biosciences IncEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesBighat Biosciences IncEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A